Adaptive laboratory evolution of Lipomyces starkeyi for high production of lignin derivative alcohol and lipids with comparative untargeted metabolomics-based analysis.

Abstract

Adaptive laboratory evolution (ALE) is an impactful technique for cultivating microorganisms to adapt to specific environmental circumstances or substrates through iterative growth and selection. This study utilized an adaptive laboratory evolution method on Lipomyces starkeyi for high tolerance in producing lignin derivative alcohols and lipids from syringaldehyde. Afterward, untargeted metabolomics analysis was employed to find the key metabolites that play important roles in the better performance of evolved strains compared to the wild type. Lignin, a prominent constituent of plant biomass, is a favorable source material for the manufacture of biofuel and lipids. Nevertheless, the effective transformation of chemicals produced from lignin into products with high economic worth continues to be a difficult task. In this study, we exposed L. starkeyi to a series of flask passaging experiments while applying selective pressure to facilitate its adaptation to syringaldehyde, a specific type of lignin monomeric aldehyde. Using ALE, we successfully developed a new strain, DALE-22, which can synthesize syringyl alcohol up to 18.74 mM from 22.28 mM syringaldehyde with 41.9% lipid accumulation. In addition, a comprehensive examination of untargeted metabolomics identified six specific crucial metabolites linked to the improved tolerance of the evolved strain in the utilization of syringaldehyde, including 2-aminobutyric acid, allantoin, 4-hydroxyphenethyl alcohol, 2-aminoethanol, tryptophan, and 5-aminovaleric acid. The results of our study reveal how L. starkeyi adapts to using substrates produced from lignin. These findings offer important information for developing strategies to improve the process of converting lignin into valuable products for sustainable biorefinery applications.